Next Article in Journal
A Novel Nomogram Based on Imaging Biomarkers of Shear Wave Elastography, Angio Planewave Ultrasensitive Imaging, and Conventional Ultrasound for Preoperative Prediction of Malignancy in Patients with Breast Lesions
Next Article in Special Issue
Prenatal Detection of Rapid Progressive Changes in Massive Lymphangioma from Flank to the Lower Extremity
Previous Article in Journal
A Review on Endoscopic Ultrasound-Guided Radiofrequency Ablation (EUS-RFA) of Pancreatic Lesions
Previous Article in Special Issue
Popcorn Appearance of Severely Calcified Uterine Leiomyoma: Image-Pathological Correlation
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Interesting Images

Placenta Previa et Percreta: A Potentially Life-Threatening Condition

Department for Women's Health, University Hospital Tübingen, 72076 Tübingen, Germany
*
Author to whom correspondence should be addressed.
Diagnostics 2023, 13(3), 539; https://doi.org/10.3390/diagnostics13030539
Submission received: 26 December 2022 / Accepted: 31 January 2023 / Published: 1 February 2023
(This article belongs to the Special Issue Interesting Images in Obstetrics and Gynecology)

Abstract

:
Placenta percreta occurs in about 5% of placenta accreta spectrum (PAS) and causes high maternal and fetal peripartum morbidity/mortality. A 34-year-old multiparous 4G2P (1xcesarean section (CS)) was admitted to hospital at the 34th week of gestation. Transvaginal ultrasound revealed a placenta previa totalis et percreta with a small tissue layer towards the bladder. Ultrasound was crucial for further planning. An interdisciplinary setting was established based on this life-threatening diagnosis. Due to the onset of labor one day later, a CS was performed. Intraoperatively, the suspicion was confirmed of a placenta previa et percreta with CS scar infiltration. Due to the life-threatening bleeding risk, simultaneous subtotal hysterectomy was needed. The diagnosis was confirmed histologically. The higher the number of previous CS, the higher the PASrate. Placenta percreta is the most severe form of this, characterized by placental invasion through the entirety of the myometrium and possibly into extrauterine tissues. This case demonstrates the great importance of prenatal diagnosis with the realization of dimensions of this very rare finding, especially with an increasing CS rate and other associated complications. Due to the close interdisciplinary cooperation of the prenatal diagnosticians, obstetricians, and anesthesiologists with optimal care in a specialized center, the otherwise high morbidity/mortality can be minimized.

Figure 1. (a) Transvaginal ultrasound: presentation of a placenta previa totalis et percreta at 34 weeks gestation with a small tissue layer (arrow) towards the urinary bladder. Placenta percreta occurs in about 5% of placenta accreta spectrum (PAS) [1,2] and causes high maternal and fetal peripartum morbidity/mortality. Ultrasound was crucial for further planning. A eutrophic fetus with regular Doppler is present. (b) Specimen: The specimen of the subtotal resected uterus is demonstrated. The uterus (1) is marked, and the placenta previa totalis et percreta (3) detected preoperatively on ultrasound in the lower uterine segment (CS scar (2)) is clearly seen. Intraoperatively, the suspicion was confirmed with a placenta previa et percreta with CS scar infiltration. Due to the life-threatening bleeding risk, simultaneous subtotal hysterectomy was needed. Placenta percreta is the most severe form, characterized by placental invasion through the entirety of the myometrium and possibly into extrauterine tissues [2]. The diagnosis was confirmed histologically. Maternal blood loss was 1.7 L (2 red-blood-cell concentrates were administered). There was a good maternal and fetal outcome (fet 2490 g, inconspicuous APGAR/pH). The most common predisposing risk factor is a previous CS [3,4], as in the case presented. The higher the number of previous CS, the higher the PASrate [2]. Typically, PAS is associated with placenta previa [3] as well. Sometimes, life-threatening hemorrhage can occur, which often requires a blood transfusion [2,5]. The gold standard treatment is cesarean hysterectomy [2]. This case demonstrates the great importance of prenatal diagnosis with immediate realization of the dimensions of this very rare finding, especially with the increasing CS rate and other associated complications [4,6,7].
Figure 1. (a) Transvaginal ultrasound: presentation of a placenta previa totalis et percreta at 34 weeks gestation with a small tissue layer (arrow) towards the urinary bladder. Placenta percreta occurs in about 5% of placenta accreta spectrum (PAS) [1,2] and causes high maternal and fetal peripartum morbidity/mortality. Ultrasound was crucial for further planning. A eutrophic fetus with regular Doppler is present. (b) Specimen: The specimen of the subtotal resected uterus is demonstrated. The uterus (1) is marked, and the placenta previa totalis et percreta (3) detected preoperatively on ultrasound in the lower uterine segment (CS scar (2)) is clearly seen. Intraoperatively, the suspicion was confirmed with a placenta previa et percreta with CS scar infiltration. Due to the life-threatening bleeding risk, simultaneous subtotal hysterectomy was needed. Placenta percreta is the most severe form, characterized by placental invasion through the entirety of the myometrium and possibly into extrauterine tissues [2]. The diagnosis was confirmed histologically. Maternal blood loss was 1.7 L (2 red-blood-cell concentrates were administered). There was a good maternal and fetal outcome (fet 2490 g, inconspicuous APGAR/pH). The most common predisposing risk factor is a previous CS [3,4], as in the case presented. The higher the number of previous CS, the higher the PASrate [2]. Typically, PAS is associated with placenta previa [3] as well. Sometimes, life-threatening hemorrhage can occur, which often requires a blood transfusion [2,5]. The gold standard treatment is cesarean hysterectomy [2]. This case demonstrates the great importance of prenatal diagnosis with immediate realization of the dimensions of this very rare finding, especially with the increasing CS rate and other associated complications [4,6,7].
Diagnostics 13 00539 g001

Author Contributions

Conceptualization, C.B. and M.H.; methodology, C.B.; validation, C.B.; formal analysis, C.B.; investigation, C.B.; resources, C.B., M.H. and H.A.; data curation, C.B.; writing—original draft preparation, C.B.; writing—review and editing, C.B., M.H. and H.A.; visualization, C.B. and M.H.; supervision, C.B.; project administration, C.B.; funding acquisition, C.B. All authors have read and agreed to the published version of the manuscript.

Funding

We acknowledge support by Open Access Publishing Fund of University of Tübingen. The funding body played no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki. The study did not require ethical approval.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study; Written informed consent has been obtained from the patient to publish this paper.

Data Availability Statement

All data regarding this case are published within it, for further questions please ask the authors.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Berman, Z.; Shiehmorteza, M.; Hahn, M.E. Ultrasonographic Diagnosis of Placenta Accreta Spectrum. Curr. Radiol. Rep. 2019, 7, 11. [Google Scholar] [CrossRef]
  2. Anderson, D.J.; Liu, H.; Kumar, D.; Patel, M.; Kim, S. Placenta Percreta Complications. Cureus 2021, 13, e18842. [Google Scholar] [CrossRef] [PubMed]
  3. Bartels, H.C.; Walsh, J.M.; O’Connor, C.; McParland, P.; Carroll, S.; Higgins, S.; Mulligan, K.M.; Downey, P.; Brophy, D.; Colleran, G.; et al. Placenta Accreta Spectrum ultrasound stage and fetal growth. Int. J. Gynecol. Obstet. 2022, 1–7. [Google Scholar] [CrossRef] [PubMed]
  4. Hoopmann, M.; Kagan, K.O. Abnormal Placentation and Umbilical Cord Insertion. Ultraschall Med.-Eur. J. Ultrasound 2020, 41, 120–137. [Google Scholar] [CrossRef] [PubMed]
  5. American College of Obstetricians and Gynecologists; Society for Maternal-Fetal Medicine. Obstetric Care Consensus No. 7.: Placenta accreta spectrum. Obs. Gynecol. 2018, 132, e259–e275. [Google Scholar] [CrossRef] [PubMed]
  6. Zeevi, G.; Tirosh, D.; Baron, J.; Sade, M.Y.; Segal, A.; Hershkovitz, R. The risk of placenta accreta following primary cesarean delivery. Arch. Gynecol. Obstet. 2018, 297, 1151–1156. [Google Scholar] [CrossRef] [PubMed]
  7. Yang, Y.; He, F. Placenta percreta complicated with uterine rupture. Arch. Gynecol. Obstet. 2022, 305, 291–292. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Bachmann, C.; Abele, H.; Hoopmann, M. Placenta Previa et Percreta: A Potentially Life-Threatening Condition. Diagnostics 2023, 13, 539. https://doi.org/10.3390/diagnostics13030539

AMA Style

Bachmann C, Abele H, Hoopmann M. Placenta Previa et Percreta: A Potentially Life-Threatening Condition. Diagnostics. 2023; 13(3):539. https://doi.org/10.3390/diagnostics13030539

Chicago/Turabian Style

Bachmann, Cornelia, Harald Abele, and Markus Hoopmann. 2023. "Placenta Previa et Percreta: A Potentially Life-Threatening Condition" Diagnostics 13, no. 3: 539. https://doi.org/10.3390/diagnostics13030539

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop